<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rpmj</journal-id><journal-title-group><journal-title xml:lang="ru">Research'n Practical Medicine Journal</journal-title><trans-title-group xml:lang="en"><trans-title>Research and Practical Medicine Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2410-1893</issn><publisher><publisher-name>"QUASAR", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17709/2409-2231-2014-1-1-80-83</article-id><article-id custom-type="elpub" pub-id-type="custom">rpmj-22</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клинические наблюдения</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical Case Reports</subject></subj-group></article-categories><title-group><article-title>КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ МЕТАСТАЗА ПОЧЕЧНО-КЛЕТОЧНОГО РАКА В ПЛЕЧЕВОЙ КОСТИ С РЕКОНСТРУКТИВНО-ПЛАСТИЧЕСКИМ ХИРУРГИЧЕСКИМ ЭТАПОМ</article-title><trans-title-group xml:lang="en"><trans-title>COMBINED TREATMENT OF RENAL CELL CARCINOMA METASTASIS LOCATED IN THE HUMERUS WITH RECONSTRUCTIVE PLASTIC SURGERY STAGE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, заместитель директора по научной и лечебной работе, МРНЦ имени А.Ф. Цыба – филиал ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России</p></bio><bio xml:lang="en"><p>MD, deputy director for research and clinical work Medical Radiology Centre of Hertsen FMRC MH RF</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клименко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, старший научный сотрудник, руководитель научной группы МРНЦ им. А.Ф. Цыба – филиал ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России Адрес: 249031, Российская Федерация, Калужская область, г. Обнинск, ул. Жукова, д. 10 Телефон: +7 (484) 399-31-30</p></bio><bio xml:lang="en"><p>PhD, senior researcher, head of research group Medical Radiology Centre of Hertsen FMRC MH RF 10, Zhukov street, Obninsk, 249036, Kaluga region, Russian Federation Теl: +7 (484) 399-31-30</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курильчик</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurilchik</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, ведущий научный сотрудник, руководитель группы лучевого и хирургического лечения опухолей костей МРНЦ им. А.Ф. Цыба – филиал ФГБУ «ФМИЦ им. П.А. Герце- на» Минздрава России</p></bio><bio xml:lang="en"><p>PhD, leading researcher Senior, Head of radiation and surgical treatment of bone tumors Medical Radiology Centre of Hertsen FMRC MH RF</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стародубцев</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Starodubtsev</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>научный сотрудник радиологического отделения МРНЦ имени А.Ф. Цыба -филиал ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России</p></bio><bio xml:lang="en"><p>researcher radiology department Medical Radiology Centre of Hertsen FMRC MH RF</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каприн</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaprin</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, член - корреспондент РАН, генеральный директор ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России</p></bio><bio xml:lang="en"><p>MD, professor, corresponding member of RAS, general director of the P.A. Herzen Federal Medical Research Center of Ministry of Health of Russian Federation</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>МРНЦ им. А.Ф. Цыба – филиал ФГБУ «ФМИЦ им. П.А. Герце на» Минздрава России (Обнинск, Российская Федерация) 249031, Российская Федерация, Калужская область, г. Обнинск, ул. Жукова, д. 10</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Radiology Centre of Hertsen FMRC MH RF (Obninsk, Russian Federation) 10, Zhukov street, Obninsk, 249036, Kaluga region, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «ФМИЦ им. П.А. Герце на» Минздрава России (Обнинск, Российская Федерация) 249036, Российская Федерация, Калужская область, г. Обнинск, ул. Королёва, д. 4</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Hertsen FMRC MH RF (Obninsk, Russian Federation) 4, st. Korolev, 249036, Russian Federation, Kaluga region, Obninsk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>16</day><month>01</month><year>2015</year></pub-date><volume>1</volume><issue>1</issue><fpage>80</fpage><lpage>83</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Иванов С.А., Клименко А.А., Курильчик А.А., Стародубцев А.Л., Каприн А.Д., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Иванов С.А., Клименко А.А., Курильчик А.А., Стародубцев А.Л., Каприн А.Д.</copyright-holder><copyright-holder xml:lang="en">Ivanov S.A., Klimenko A.A., Kurilchik A.A., Starodubtsev A.L., Kaprin A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpmj.ru/rpmj/article/view/22">https://www.rpmj.ru/rpmj/article/view/22</self-uri><abstract><p>В последние годы эффективность проводимого лечения даже запущенных случаев метастатического рака почки относительно высока, благодаря возможности проведения таргетной терапии, удаления метастатических очагов, в связи с чем, нередко на первый план выходит качество жизни этих пациентов. В настоящей статье описан клинический случай радикального хирургического лечения метастаза в плечевую кость с частичным восстановлением функции конечности, что в итоге привело к улучшению качества жизни пациента.</p></abstract><trans-abstract xml:lang="en"><p>In the recent years, the effectiveness of the treatment of even advanced cases of metastatic renal cell carcinoma is relatively high due to the possibility of targeted therapy, removal of metastatic lesions. Therefore, the issue of the quality of life of such patients often comes to the fore. This paper presents a clinical case of radical surgical treatment of metastasis located in the humerus, resulting in partial recovery of the limb function which eventually led to the improvement of the patient’s quality of life.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>почечно-клеточный рак</kwd><kwd>метастатическое поражение костей</kwd><kwd>таргетная терапия</kwd><kwd>метастазэктомия</kwd><kwd>остеосинтез</kwd><kwd>качество жизни</kwd></kwd-group><kwd-group xml:lang="en"><kwd>renal cell carcinoma</kwd><kwd>metastatic bone lesions</kwd><kwd>targeted therapy</kwd><kwd>metastasectomy</kwd><kwd>osteosynthesis</kwd><kwd>quality of life</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kaprin A.D., Starinskij V.V., Petrova G.V. lokachestvennye novoobrazovanija v Rossii v 2012 godu [Kniga]. - M : FGBU «MNIOI im. P.A. Gercena» Minzdrava Rossii, 2014. - str. 250.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinskij V.V., Petrova G.V. lokachestvennye novoobrazovanija v Rossii v 2012 godu [Kniga]. - M : FGBU «MNIOI im. P.A. Gercena» Minzdrava Rossii, 2014. - str. 250.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Alekseev B.Ja., Kalpinskij A.S., Njushko K.M. Opredelenie faktorov prognoza jeffektivnosti terapii bevacizumabom u bol’nyh metastaticheskim pochechno-kletochnym rakom [Zhurnal] // Onkourologija. - 2013 g. - T. 3. - str. 17–24.</mixed-citation><mixed-citation xml:lang="en">Alekseev B.Ja., Kalpinskij A.S., Njushko K.M. Opredelenie faktorov prognoza jeffektivnosti terapii bevacizumabom u bol’nyh metastaticheskim pochechno-kletochnym rakom [Zhurnal] // Onkourologija. - 2013 g. - T. 3. - str. 17–24.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Motzer R.J., Masumdar M., Bacic J. et al. Survival and prognostic stratification of 670 patients with advanced renal cell sarcinoma [Journal] // J Clin Oncol. - 1999. - Vol. 17. - pp. 2530–40.</mixed-citation><mixed-citation xml:lang="en">Motzer R.J., Masumdar M., Bacic J. et al. Survival and prognostic stratification of 670 patients with advanced renal cell sarcinoma [Journal] // J Clin Oncol. - 1999. - Vol. 17. - pp. 2530–40.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer [Online]. - 2009. - V.1.2009. - 11 15, 2014. - http://www. calcuttayellowpages.com/cimagE25/109180kidney.pdf.</mixed-citation><mixed-citation xml:lang="en">National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer [Online]. - 2009. - V.1.2009. - 11 15, 2014. - http://www. calcuttayellowpages.com/cimagE25/109180kidney.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Di Lorenzo G., Autorino R., Sternberg C.N. Metastatic renal cell carcinoma: recent advances in the targeted therapy era [Journal] // Eur. Urol. - 2009. - Vol. 56. - pp. 1959–71.</mixed-citation><mixed-citation xml:lang="en">Di Lorenzo G., Autorino R., Sternberg C.N. Metastatic renal cell carcinoma: recent advances in the targeted therapy era [Journal] // Eur. Urol. - 2009. - Vol. 56. - pp. 1959–71.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Escudier B., Eisen T., Porta C. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [Zhurnal] // Ann. Oncol. - 2012 g. - T. 23. - str. vii65–vii71.</mixed-citation><mixed-citation xml:lang="en">Escudier B., Eisen T., Porta C. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [Zhurnal] // Ann. Oncol. - 2012 g. - T. 23. - str. vii65–vii71.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Feldman D.R., Kondagunta G.V., Ronnen E.A. et al. Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC). Proc. ASCO [Journal] // J. Clin. Oncol. - 2007. - Vol. 25. - p. 5099.</mixed-citation><mixed-citation xml:lang="en">Feldman D.R., Kondagunta G.V., Ronnen E.A. et al. Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC). Proc. ASCO [Journal] // J. Clin. Oncol. - 2007. - Vol. 25. - p. 5099.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tepljakov V.V., Karpenko V.Ju., Buharov A.V. Intervencionnye metody lechenija pri opuholevom porazhenii kostej [Zhurnal] // Sarkomy kostej, mjagkih tkanej i opuholi kozhi. - 2010 g. - T. 1. - str. 21–25.</mixed-citation><mixed-citation xml:lang="en">Tepljakov V.V., Karpenko V.Ju., Buharov A.V. Intervencionnye metody lechenija pri opuholevom porazhenii kostej [Zhurnal] // Sarkomy kostej, mjagkih tkanej i opuholi kozhi. - 2010 g. - T. 1. - str. 21–25.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Semenov N.N. Osobennosti kostnyh metastazov razlichnyh solidnyh opuholej [Zhurnal] // Sarkomy kostej, mjagkih tkanej i opuholi kozhi. - 2011 g. - T. 1. - str. 11-18.</mixed-citation><mixed-citation xml:lang="en">Semenov N.N. Osobennosti kostnyh metastazov razlichnyh solidnyh opuholej [Zhurnal] // Sarkomy kostej, mjagkih tkanej i opuholi kozhi. - 2011 g. - T. 1. - str. 11-18.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
